One patient with FGFR1 K656E grade II diffuse astrocytoma had a partial response (patient 100) and one patient with an FGFR1 N546K low-grade pediatric type glioma had stable disease and a 6.2-month PFS. This evidence concerns the gene FGFR1 and central nervous system cancer.